Aug 30, 2026•1 min read
LIGACEM BioScience Unveils LCB 2.0 R&D Strategy Targeting ADC Innovation and Next‑Gen Modalities
LIGACEM BioScience announced its LCB 2.0 R&D roadmap at Global R&D Day 2026, aiming to boost ADC innovation, expand into next‑generation modalities and accelerate high‑value technology transfer.